Search research articles
Contact Us
Filters
Showing results (591-600 of 671) with videos related to
Page
of 68
Sort By:
Immunohorizons
|
June 8, 2023
A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept
Edwin J Ostrin, Nicholas L Rider, Amin M Alousi, et al.
American Journal of Hematology
|
October 10, 2019
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation
Samer A Srour, Rima M Saliba, Maria C B Bittencourt, et al.
Blood Advances
|
September 13, 2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Stefan O Ciurea, Maria Cecilia Borges Bittencourt, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
January 16, 2023
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience
Oren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, et al.
British Journal of Haematology
|
July 6, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma
Curtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Blood Advances
|
December 3, 2021
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo
Xiaoshan Zhang, Ran Zhang, Chenghui Ren, et al.
Transplantation and Cellular Therapy
|
March 25, 2022
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation
Aimaz Afrough, Oren Pasvolsky, Junsheng Ma, et al.
Blood Cancer Journal
|
January 10, 2024
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
June 9, 2024
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades
Oren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.
Blood
|
June 11, 2021
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia
Tomoyuki Tanaka, Kiyomi Morita, Sanam Loghavi, et al.
Page
of 68
Search research articles
Search
Showing results (591-600 of 671) with videos related to
Sort By:
Page
of 68
Immunohorizons
|
June 8, 2023
A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept
Edwin J Ostrin, Nicholas L Rider, Amin M Alousi, et al.
American Journal of Hematology
|
October 10, 2019
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation
Samer A Srour, Rima M Saliba, Maria C B Bittencourt, et al.
Blood Advances
|
September 13, 2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Stefan O Ciurea, Maria Cecilia Borges Bittencourt, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
January 16, 2023
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience
Oren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, et al.
British Journal of Haematology
|
July 6, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma
Curtis Marcoux, Denái R Milton, Mark R Tanner, et al.
Blood Advances
|
December 3, 2021
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo
Xiaoshan Zhang, Ran Zhang, Chenghui Ren, et al.
Transplantation and Cellular Therapy
|
March 25, 2022
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation
Aimaz Afrough, Oren Pasvolsky, Junsheng Ma, et al.
Blood Cancer Journal
|
January 10, 2024
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Transplantation and Cellular Therapy
|
June 9, 2024
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades
Oren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.
Blood
|
June 11, 2021
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia
Tomoyuki Tanaka, Kiyomi Morita, Sanam Loghavi, et al.
Page
of 68